stars 1 stars 2 stars 3

Doctors and patients increasingly ask AI about diseases, treatments and medicines. The answers can be incomplete, outdated or one-sided, and most pharma teams cannot see them. ceel.ai shows Medical Affairs and Commercial teams what AI says about their therapy area, which sources appear in those answers, and what to change before an inaccurate narrative scales. Being mentioned is not the same as being represented correctly. So we look beyond visibility, at scientific accuracy, context and evidence, and turn it into concrete work for your teams: • Congress: see how new data is picked up by AI before, during and after major congresses. • Compliance Shield: spot answers that drift into off-label, outdated or unbalanced territory early. • Publication Planner: find where AI answers lack your evidence and feed that into publication planning. Built for pharma, with scientific accuracy and regulatory boundaries first. Narrative-to-Action for Pharma.

ceel.ai Questions

Daniel Weimer is the Co-Founder of ceel.ai.

3 people are employed at ceel.ai.

Top ceel.ai Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users